Publications by authors named "Dei Tos Angelo Paolo"

: Splenectomy leads to a high rate of remission in chronic primary immune thrombocytopenia (ITP), but its unpredictable long-term positive outcomes and that it is a irreversible surgical approach discourage clinicians and patients. The identification of predictors of response may redefine the timing of splenectomy. In this retrospective, multicentric study we aimed to investigate clinical-histological predictors of splenectomy response in ITP patients and provide an easy-to-use score to predict splenectomy response in ITP.

View Article and Find Full Text PDF

Pathology laboratories are currently facing remarkable issues in the management of their archives due to the ongoing increase in the production of formalin-fixed paraffin-embedded (FFPE) blocks, which is often coupled with inadequate spatial and environmental storing conditions. The manual process of storage and retrieving further increases the likelihood of human-based mistakes, wastes professionals' working time, and, ultimately, widens reports signing turn-around times. In the present work, we outline the strategies underlying the development of an automated archive at the pathology services of the University of Modena.

View Article and Find Full Text PDF

Background: RAS/BRAF mutations, mismatch DNA repair complex deficiency (MMRd)/microsatellite instability (MSI), and CpG methylator phenotype (CIMP) are key molecular actors in colorectal carcinogenesis. To date, conflicting evidence about the correlations between these molecular features has been reported.

Materials And Methods: A retrospectively selected cohort of 123 CRCs was divided into 3 groups based on the molecular characteristics: MMR proficient (MMRp)/BRAF p.

View Article and Find Full Text PDF

Aims: The diagnosis of lymphoplasmacytic lymphoma (LPL) in the bone marrow (BM) is challenged by aberrant phenotypes and by overlapping histological features with marginal zone lymphoma (MZL). To address these issues, we (i) assessed LPL immunophenotype on a large series of BM samples, (ii) drew possible correlations between LPL phenotype and clinical/molecular data and (iii) investigated the role of new phenotypical markers in the differential diagnosis between LPL and MZL.

Materials And Methods: The study retrospectively considered 81 clinically annotated LPL diagnosed at Padua University Hospital (Padua, Italy) during a 5-year period.

View Article and Find Full Text PDF

Hidradenocarcinoma (HAC) is a rare malignant neoplasm originating from eccrine sweat glands, often presenting diagnostic challenges because of its resemblance to other malignancies, particularly breast cancer when occurring in the chest region. This report describes 2 cases of HAC with axillary lymph node metastasis, both initially misinterpreted clinically. The first case involved a 63-year-old woman with a sternal mass, near the right breast, initially suspected to be a sebaceous cyst.

View Article and Find Full Text PDF

Lynch syndrome is rarely associated with rectal cancer (RC) and thus, metachronous RC has been scarcely investigated. This study aimed to analyze the mucosal immune microenvironment in sporadic and metachronous RC. We analyzed the mucosal immune microenvironment in the 25 metachronous RCs present in the IMMUNOREACT 1 and 2 multicentre observational studies (624 patients).

View Article and Find Full Text PDF

Background: Transanal excision of rectal cancer can be considered the definitive surgical treatment if the depth spread is T1 or lower, and the lesion is completely included within the resection margin. This study aims to analyze the immune microenvironment in healthy rectal mucosa as a possible predictor of tumor infiltration depth, lateral tumor spread, and recurrence of rectal cancer after transanal local excision.

Methods: This study is a subanalysis of data from the IMMUNOREACT 1 and 2 trials (NCT04915326 and NCT04917263, respectively) including all the patients who underwent transanal excision of rectal cancer.

View Article and Find Full Text PDF

Epithelioid sarcoma (ES) is a rare tumor hallmarked by the loss of INI1/SMARCB1 expression. Apart from this alteration, little is known about the biology of ES. Despite recent advances in treatment, the prognosis of ES remains unsatisfactory.

View Article and Find Full Text PDF
Article Synopsis
  • Burkitt lymphoma (BL) is a common type of B-cell lymphoma in kids, with many being cured but some showing resistance to treatment.
  • Researchers used single-cell transcriptomics to study the differences between patients who respond to therapy and those who don’t, finding that non-responders have more immune cells and a specific gene, Tropomyosin 2 (TPM2), highly expressed in their tumors.
  • The study suggests that the level of TPM2 can help predict treatment outcomes for BL patients, highlighting the disease's genetic diversity and potential biomarkers for therapy resistance.
View Article and Find Full Text PDF
Article Synopsis
  • Pathology is essential for accurately diagnosing skin tumors, which is important for creating tailored treatment plans and improving patient care in dermatology.
  • The updated WHO classification of skin tumors includes new sections on nail unit tumors, skin metastases, and genetic syndromes, alongside advancements in understanding various skin tumors on molecular levels.
  • Recent findings, particularly regarding melanocytic tumors, have led to new terminology and an integrated diagnostic approach that emphasizes morphology, immunohistochemistry, and molecular features, aiding clinical decision-making and fostering collaboration in treatment development.
View Article and Find Full Text PDF
Article Synopsis
  • The "Galileo" is an AI tool that helps doctors understand kidney biopsy results better and faster before a transplant.
  • It was trained using images of kidney biopsies to recognize important things, like normal and damaged parts of the kidney.
  • Galileo works much quicker than human doctors, taking only 2 minutes to analyze samples compared to around 25-31 minutes for doctors, which can help improve kidney transplant success.
View Article and Find Full Text PDF
Article Synopsis
  • Epithelioid hemangioendothelioma (EHE) is a rare type of cancer with unique features, but its natural history and best treatment practices are not well understood.
  • The EURACAN project has created a registry to gather prospective data on newly diagnosed EHE patients to enhance understanding of the disease.
  • The study will involve collecting comprehensive patient data from specialized hospitals to identify prognostic factors, treatment efficacy, and to monitor the disease's progression and outcomes over time.
View Article and Find Full Text PDF
Article Synopsis
  • - The study analyzed how anthracycline-based neoadjuvant chemotherapy (NAC) affects immune cells' spatial distribution in high-risk soft tissue sarcomas (STS) and how this relates to patient outcomes.
  • - Researchers examined various tumor areas for specific immune cells using advanced pathology techniques and created a sarcoma immune index (SIS) to predict disease-free and overall survival rates.
  • - Findings revealed that certain immune cell types, particularly PD-1+ and CD20+ B-cells, correlated with prognosis differently based on their locations within the tumor, highlighting NAC's role in altering tumor immune characteristics.
View Article and Find Full Text PDF

Malignant Peripheral Nerve Sheath Tumors (MPNSTs) are aggressive sarcomas that can arise both sporadically and in patients with the genetic syndrome Neurofibromatosis type 1 (NF1). Prognosis is dismal, as large dimensions, risk of relapse, and anatomical localization make surgery poorly effective, and no therapy is known. Hence, the identification of MPNST molecular features that could be hit in an efficient and selective way is mandatory to envision treatment options.

View Article and Find Full Text PDF
Article Synopsis
  • The Meet-URO 18 study investigates metastatic renal cell carcinoma patients undergoing nivolumab treatment in two distinct groups based on their progression-free survival (PFS) times.
  • The study utilizes detailed immunohistochemical analysis to assess various markers like T-lineage markers (CD3, CD4, CD8), macrophages (CD68), and PD-L1 expression in tumor samples from 113 patients, significantly expanding upon previous data.
  • Results indicate that tumor tissue with lower CD4 and higher CD56 expression correlates with a more favorable antitumor response, suggesting the potential of CD56 as a biomarker for immunotherapy effectiveness.
View Article and Find Full Text PDF

Nowadays pathology laboratories are worldwide facing a digital revolution, with an increasing number of institutions adopting digital pathology (DP) and whole slide imaging solutions. Despite indeed providing novel and helpful advantages, embracing a whole DP workflow is still challenging, especially for wide healthcare networks. The Azienda Zero of the Veneto Italian region has begun a process of a fully digital transformation of an integrated network of 12 hospitals producing nearly 3 million slides per year.

View Article and Find Full Text PDF
Article Synopsis
  • * The study involves detailed analysis of various immune markers in tumor samples, including T-cell markers (CD3, CD4, CD8), macrophage presence (CD68), and PD-L1 expression, now with an expanded sample size of 161 tumors from 113 patients.
  • * Findings indicate that lower CD4 levels and higher CD8/CD4 ratios correlate with certain tumor characteristics, suggesting a specific T-cell subpopulation plays a role in anti-tumor response; CD56 might serve as a potential
View Article and Find Full Text PDF

In the molecular era, proper archival conditions within pathology laboratories are crucial, especially for formalin-fixed paraffin-embedded (FFPE) tissue specimens retrieved years after the original diagnosis. Indeed, improper preservation can impact the integrity of nucleic acids and protein antigens. This study evaluates the quality status of stored FFPE blocks using multilevel omics approaches.

View Article and Find Full Text PDF

Background: Long-term daily use of aspirin reduces incidence and mortality due to colorectal cancer (CRC). This study aimed to analyze the effect of aspirin on the tumor microenvironment, systemic immunity, and on the healthy mucosa surrounding cancer.

Methods: Patients with a diagnosis of CRC operated on from 2015 to 2019 were retrospectively analyzed (METACCRE cohort).

View Article and Find Full Text PDF

Angiosarcoma (AS) represents a rare and aggressive vascular sarcoma, posing distinct challenges in clinical management compared to other sarcomas. While the current European Society of Medical Oncology (ESMO) clinical practice guidelines for sarcoma treatment are applicable to AS, its unique aggressiveness and diverse tumor presentations necessitate dedicated and detailed clinical recommendations, which are currently lacking. Notably, considerations regarding surgical extent, radiation therapy (RT), and neoadjuvant/adjuvant chemotherapy vary significantly in localized disease, depending on each different site of onset.

View Article and Find Full Text PDF